Antipodes Partners’s Crown Castle CCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Buy
1,674,362
+50,182
+3% +$4.41M 2.32% 14
2026
Q1
$132M Buy
1,624,180
+199,718
+14% +$17.2M 2.54% 14
2025
Q4
$127M Buy
1,424,462
+163,020
+13% +$15M 2.66% 11
2025
Q3
$122M Buy
+1,261,442
New +$128M 2.73% 14

Other funds holding CCI

Antipodes Partners's CCI Position: Q2 2026 in Review

Antipodes Partners increased its Crown Castle (CCI) stake by 3.1% in Q2 2026, buying an estimated $4.41M and bringing the position to 1,674,362 shares worth $127M. The position accounts for 2.32% of the portfolio, ranked #14.

Antipodes Partners first reported a position in CCI in Q3 2025 and has held it in 4 quarters since. The position peaked at $132M in Q1 2026. 933 funds tracked by Wall St. Rank hold CCI as of Q2 2026.

  • Antipodes Partners held 1,674,362 shares of Crown Castle worth $127M as of Q2 2026.
  • Antipodes Partners bought 50,182 Crown Castle shares in Q2 2026, an estimated $4.41M.
  • Crown Castle made up 2.32% of Antipodes Partners's portfolio in Q2 2026, its #14 holding.
  • Antipodes Partners first reported a position in Crown Castle in Q3 2025 and has held it in 4 quarters since.
  • Antipodes Partners's Crown Castle position peaked at $132M in Q1 2026.
  • 933 funds tracked by Wall St. Rank held Crown Castle as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.